Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials

Overview of attention for article published in Clinical Ophthalmology, June 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 61 Dimensions

Readers on

mendeley: 48 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 61 publications that cite this research output.

61

The most recent citing publications are shown below. View all 61 publications that cite this research output on Dimensions.

Real‐world experiences with intravitreal treatment with ranibizumab and aflibercept for diabetic macular oedema 2008–2021

Article in Acta Ophthalmologica (March 2024)

The Treatment of Diabetic Retinal Edema with Intravitreal Steroids: How and When

Article in Journal of Clinical Medicine (February 2024)

BETTER BASELINE VISION LEADS TO BETTER OUTCOMES AFTER THE 0.19-mg FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT IN DIABETIC MACULAR EDEMA

Article in Retina (August 2023)